Abstract

Acinetobacter calcoaceticus–baumannii complex is a common cause of hospital-acquired infections (HAIs) globally, remarkable for its high rate of antibiotic resistance, including to carbapenems. There are few data on the resistance of A. baumannii in Vietnam, which are essential for developing evidence-based treatment guidelines for HAIs. Antibiotic susceptibility testing was conducted by VITEK®2, and pulsed-field gel electrophoresis (PFGE) was performed on 66 clinical A. baumannii complex isolates recovered during 2009 at the National Hospital of Tropical Diseases (NHTD), a referral hospital in Hanoi, Vietnam. Basic demographic and clinical data were collected and analysed using descriptive statistics. Most isolates came from lower respiratory tract specimens (59; 89.4%) from intensive care unit (ICU) patients [64/65 (98.5%) with available data] who had been admitted to NHTD for ≥2 days [42/46 (91.3%) with available data]. More than 90% of the isolates were resistant to the tested β-lactamase/β-lactamase inhibitors, cephalosporins, carbapenems, fluoroquinolones and trimethoprim/sulfamethoxazole. Moreover, 25.4% (16/63) were resistant to all tested β-lactams, quinolones and aminoglycosides. All isolates remained sensitive to colistin and 58.7% were susceptible to tigecycline. Of the 66 isolates, 49 could be classified into eight PFGE types (A–H). Every PFGE type, except D, had cluster(s) of three or more isolates with a temporal relationship. In conclusion, these data suggest a significant rise in A. baumannii antibiotic resistance in Vietnam. Clustering within PFGE types supports cross-transmission of A. baumannii within the ICU at NHTD. Increased research and resources in optimising treatment, infection control and antibiotic stewardship are needed.

Highlights

  • Acinetobacter calcoaceticus–baumannii complex is emerging as one of the most common causes of hospital-acquired infections (HAIs) in intensive care units (ICUs) worldwide and is often resistant to multiple antibiotic classes, complicating treatment [1].Acinetobacter baumannii is a strictly aerobic, non-motile, Gramnegative bacillus belonging to the A. calcoaceticus–baumannii complex within the family Moraxellaceae of the order Gammaproteobacteria

  • This study describes the antibiotic susceptibility and molecular epidemiology of A. baumannii isolates from a referral hospital in Hanoi, Vietnam

  • Almost all patients were admitted to the ICU (64/65 with available data)

Read more

Summary

Introduction

Acinetobacter calcoaceticus–baumannii complex is emerging as one of the most common causes of hospital-acquired infections (HAIs) in intensive care units (ICUs) worldwide and is often resistant to multiple antibiotic classes, complicating treatment [1].Acinetobacter baumannii is a strictly aerobic, non-motile, Gramnegative bacillus belonging to the A. calcoaceticus–baumannii complex within the family Moraxellaceae of the order Gammaproteobacteria. Acinetobacter calcoaceticus–baumannii complex is emerging as one of the most common causes of hospital-acquired infections (HAIs) in intensive care units (ICUs) worldwide and is often resistant to multiple antibiotic classes, complicating treatment [1]. Identification by phenotypic methods or DNA– DNA hybridisation does not reliably distinguish A. baumannii from other members of the A. calcoaceticus–baumannii complex ( referred to as A. baumannii) [1]. This poses challenges clinically because A. baumannii can be pathogenic whereas A. calcoaceticus is environmental.

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.